Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$13.89 - $15.04 $14,612 - $15,822
1,052 Added 9.64%
11,961 $166,000
Q4 2023

Jan 29, 2024

SELL
$13.36 - $15.43 $2,765 - $3,194
-207 Reduced 1.86%
10,909 $155,000
Q3 2023

Oct 30, 2023

BUY
$15.03 - $16.32 $167,073 - $181,413
11,116 New
11,116 $171,000
Q1 2021

May 17, 2021

SELL
$16.71 - $19.9 $34,840 - $41,491
-2,085 Closed
0 $0
Q4 2020

Jan 28, 2021

BUY
$15.39 - $18.97 $32,088 - $39,552
2,085 New
2,085 $38,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $44.4B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Perigon Wealth Management, LLC Portfolio

Follow Perigon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perigon Wealth Management, LLC with notifications on news.